Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Jun 5;2(6):e195463.
doi: 10.1001/jamanetworkopen.2019.5463.

Effect of Brief Admission to Hospital by Self-referral for Individuals Who Self-harm and Are at Risk of Suicide: A Randomized Clinical Trial

Sofie Westling  1 , Daiva Daukantaite  2 , Sophie I Liljedahl  1   2 , Youngha Oh  3 , Åsa Westrin  1 , Lena Flyckt  4 , Marjolein Helleman  5
Affiliations
Randomized Controlled Trial

Effect of Brief Admission to Hospital by Self-referral for Individuals Who Self-harm and Are at Risk of Suicide: A Randomized Clinical Trial

Sofie Westling et al. JAMA Netw Open. .

Erratum in

  • Error in Table.
    [No authors listed] [No authors listed] JAMA Netw Open. 2019 Oct 2;2(10):e1913724. doi: 10.1001/jamanetworkopen.2019.13724. JAMA Netw Open. 2019. PMID: 31584677 Free PMC article. No abstract available.

Abstract

Importance: To our knowledge, there is no consensus regarding when individuals who repeatedly self-harm and are at risk of suicide should be hospitalized. To evaluate a new alternative, we examined the effects of brief admission (BA) to hospital by self-referral.

Objectives: To determine the effects of BA on inpatient service use and on secondary outcomes of daily life functioning, nonsuicidal self-injuries, and attempted suicide among individuals who self-harm and are at risk of suicide.

Design, setting, and participants: The single-masked Brief Admission Skåne Randomized Clinical Trial was conducted from September 2015 to June 2018 at 4 psychiatric health care facilities in southern Sweden. Data were collected 6 months retrospectively at baseline and at 6-month and 12-month follow-ups. Participants were randomized to either BA and treatment as usual (BA group) or treatment as usual (control group). The sample was a referral population, with the most important inclusion criteria being current episodes of self-harm and/or recurrent suicidality, at least 3 diagnostic criteria for borderline personality disorder, and hospitalization in the last 6 months.

Interventions: Self-referred BA was offered for 12 months, with standard limits for duration and frequency, after the negotiation of a contract outlining the intervention.

Main outcomes and measures: Prespecified main outcome measures were days admitted to the hospital, including voluntary admission, BA, and compulsory admission.

Results: The 125 participants had a mean (SD) age of 32.0 (9.4) years, 106 (84.8%) were women, and 63 were randomized to the BA group and 62 to the control group. No significant advantage was observed in the number of days in the hospital for the BA group compared with the control group. Within-group analyses demonstrated significant decreases in both groups regarding days admitted to the hospital (BA group: χ2 = 22.71; P < .001; control group: χ2 = 23.01; P < .001) and visits to the emergency department (BA group: χ2 = 13.95; P < .001; control group: χ2 = 21.61; P < .001), but only the BA group showed a reduction in days with compulsory admission (χ2 = 7.67; P = .02) and nonsuicidal self-injuries (χ2 = 6.13; P = .047). The BA group showed significantly greater improvements in the mobility domain of daily life functioning (z = -2.39; P = .02) and significant within-group improvements in 3 other domains (cognition: F = 9.02; P < .001; domestic responsibilities: F = 3.23; P = .049; and participation: F = 3.79; P = .03).

Conclusions and relevance: Brief admission appears no more efficacious in reducing use of inpatient services than usual care for individuals who self-harm and are at risk of suicide. Future studies should explore other possible beneficial effects.

Trial registration: ClinicalTrials.gov identifier: NCT02985047.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure.
Figure.. CONSORT Diagram of Participant Flow During the Study
See this image and copyright information in PMC

References

    1. Koekkoek B, van der Snoek R, Oosterwijk K, van Meijel B. Preventive psychiatric admission for patients with borderline personality disorder: a pilot study. Perspect Psychiatr Care. 2010;46(2):-. doi:10.1111/j.1744-6163.2010.00248.x - DOI - PubMed
    1. Strand M, von Hausswolff-Juhlin Y. Patient-controlled hospital admission in psychiatry: a systematic review. Nord J Psychiatry. 2015;69(8):574-586. doi:10.3109/08039488.2015.1025835 - DOI - PubMed
    1. Sigrunarson V, Moljord IEO, Steinsbekk A, Eriksen L, Morken G. A randomized controlled trial comparing self-referral to inpatient treatment and treatment as usual in patients with severe mental disorders. Nord J Psychiatry. 2017;71(2):120-125. doi:10.1080/08039488.2016.1240231 - DOI - PubMed
    1. Thomsen CT, Benros ME, Maltesen T, et al. . Patient-controlled hospital admission for patients with severe mental disorders: a nationwide prospective multicentre study. Acta Psychiatr Scand. 2018;137(4):355-363. doi:10.1111/acps.12868 - DOI - PubMed
    1. Holth F, Walby F, Røstbakken T, et al. . Extreme challenges: psychiatric inpatients with severe self-harming behavior in Norway: a national screening investigation. Nord J Psychiatry. 2018;72(8):605-612. doi:10.1080/08039488.2018.1511751 - DOI - PubMed

Publication types

Associated data